Chest Medicine (all articles)
Face Coverings for the Public: Laying Straw Men to Rest, by Trisha Greenhalgh
28 May, 2020 | 09:57h | UTCFace coverings for the public: Laying straw men to rest – Journal of Evaluation in Clinical Practice
Related: Face coverings for the lay public: an alternative view – CEBM Oxford AND Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach – Annals of Internal Medicine
Unusual in 2 ways
1. "I address charges that my coauthors and I had misapplied the precautionary principle; drawn conclusions that were not supported …"
2. Best review on the essentiality of masks, debunking the naysayers
Thanks @trishgreenhalgh ?https://t.co/wZrep7BQ8U pic.twitter.com/n052R1RvsL— Eric Topol (@EricTopol) May 27, 2020
Systematic Review: Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19
28 May, 2020 | 09:59h | UTC
Perspective: Reducing Transmission of SARS-CoV-2
28 May, 2020 | 09:55h | UTCReducing transmission of SARS-CoV-2 – Science
Remdesivir for Covid-19: A 5-day Course is Similarly Effective as a 10-day Course
28 May, 2020 | 10:00h | UTCRemdesivir for 5 or 10 Days in Patients with Severe Covid-19 – New England Journal of Medicine
Study: Loss of Smell and Taste in 2013 Patients with Mild to Moderate COVID-19
27 May, 2020 | 02:35h | UTC
CDC Updated Guidance: When You Can be Around Others After You Had or Likely Had COVID-19
27 May, 2020 | 02:37h | UTC“I think or know I had COVID-19, and I had symptoms.”
You can be with others after:
- 3 days with no fever AND
- Symptoms improved AND
- 10 days since symptoms first appeared”
Clinical Guidance: Advanced Pulmonary and Cardiac Support of COVID-19 Patients
27 May, 2020 | 02:27h | UTC
Just the Facts: What Drugs are Safe and Effective for COVID-19?
27 May, 2020 | 02:31h | UTCRelated Guidelines: NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health AND Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Infection
“Apart from supportive care, there are no current effective therapeutics for COVID-19”
A Guide to COVID-19: A Global Pandemic Caused by the Novel Coronavirus SARS-CoV-2
27 May, 2020 | 02:22h | UTCA Guide to COVID-19: A Global Pandemic Caused by the Novel Coronavirus SARS-CoV-2 – The FEBS Journal
Duration of Prone Position Sessions: A Prospective Cohort Study
27 May, 2020 | 02:20h | UTCDuration of prone position sessions: a prospective cohort study – Annals of Intensive Care
Meta-analysis: Efficacy and Safety of Convalescent Plasma for Severe COVID-19
27 May, 2020 | 02:21h | UTC
Podcast: Evidence-Based Medicine for the Management of COVID-19 ARDS
26 May, 2020 | 09:57h | UTCRelated Perspective from the Author: In Defense of Evidence-Based Medicine for the Treatment of COVID-19 ARDS – Annals of the American Thoracic Society
Study: Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients
26 May, 2020 | 09:43h | UTC
Perspective: “Here’s What Needs to Happen Before We Can All Get Vaccinated for COVID-19”
26 May, 2020 | 09:45h | UTCHere’s what needs to happen before we can all get vaccinated for COVID-19 – CBC
WHO Pauses Hydroxychloroquine Arm Of COVID-19 Clinical Trial Due to Safety Concerns
26 May, 2020 | 09:35h | UTCSee also: WHO halts hydroxychloroquine trial for coronavirus amid safety fears – The Guardian AND WHO Halts Hydroxychloroquine Trial Over Safety Concerns – NPR
Remdesivir for the Treatment of Covid-19 — Preliminary Report
25 May, 2020 | 02:06h | UTCRemdesivir for the Treatment of Covid-19 — Preliminary Report – New England Journal of Medicine
Commentaries: Preliminary report on NIAID trial of remdesivir – PulmCrit AND Peer-reviewed data shows remdesivir for COVID-19 improves time to recovery – National Institutes of Health AND Covid-19 study details benefits of treatment with remdesivir, and also its limitations – STAT
Related Commentary on Twitter (Thread – Click for more)
I finished reading the Remdesivir trial
If you want my thoughts you will have to read this thread
[Thread] pic.twitter.com/GqA30lCOLI
— Vinay Prasad (@VPrasadMDMPH) May 23, 2020
Perspective: The World May Be Overestimating the Power of Vaccines
25 May, 2020 | 01:55h | UTCThe world needs Covid-19 vaccines. It may also be overestimating their power – STAT
Hydroxychloroquine and Chloroquine for Covid-19: Large Observational Analysis Finds No Benefit and Possible Harm
25 May, 2020 | 02:03h | UTCCommentaries: Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous? – The Lancet AND What a big new study on malaria drugs as Covid-19 treatments tells us — and what it doesn’t – STAT AND Hydroxychloroquine May Cause More Harm Than Benefit To COVID-19 Patients, Says New Lancet Study – Health Policy Watch
Opinion: Why Countries Should Stop Using Anti-malarial Drugs for COVID-19
25 May, 2020 | 02:02h | UTCWhy countries should stop using anti-malarial drugs for COVID-19 – The Conversation
Editorial – SARS-CoV2 Vaccines: Slow is Fast
25 May, 2020 | 01:54h | UTCSARS-CoV2 vaccines: Slow is fast – Science
Promising Early Results with New Vaccine from China in Phase I Trial
25 May, 2020 | 01:57h | UTCCommentaries: First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response – The Lancet AND Early Study Of Covid-19 Vaccine Developed In China Sees Mixed Results – Forbes AND Coronavirus Vaccine Shows Promising Early Results in China – The New York Times AND A Chinese biotech just published the first human data for its coronavirus vaccine candidate, supporting further trials – Business Insider AND Experts skeptical after researchers report positive vaccine results – CNN AND Two COVID-19 Vaccine Candidates Induce Immune Response In Healthy Volunteers – Health Policy Watch
Study: 10 of 60 Patients Treated for COVID-19 Persisted with Positive RT-PCR Results from 4 to 24 Days After Hospital Discharge
25 May, 2020 | 01:50h | UTCCommentaries: Expert reaction to study on PCR testing results from 60 people after clinical recovery from COVID-19 – Science Media Centre AND 16% of recovered patients test positive for COVID-19 weeks after discharge: study – UPI
Systematic Review: Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19
25 May, 2020 | 01:40h | UTC
Meta-Analysis: Corticosteroids May Reduce Mortality for Patients with COVID-19 and ARDS
25 May, 2020 | 01:45h | UTC
Clinical Guidance: Thromboembolism and Anticoagulant Therapy During the COVID-19 Pandemic
25 May, 2020 | 01:43h | UTCRelated: Coagulation abnormalities and thrombosis in patients with COVID-19 – The Lancet AND COVID-19 and its implications for thrombosis and anticoagulation – Blood AND Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines – Thrombosis and Haemostasis AND Thrombosis and COVID-19: FAQs For Current Practice – American College of Cardiology